We are live on ! Find out more
ITCI

Intra-Cellular Therapies Inc.
ITCI

Delisted

ITCI was delisted on the 1st of April, 2025.

Back to rankings

139 hedge funds and large institutions have $1.19B invested in Intra-Cellular Therapies Inc. in 2016 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 58 increasing their positions, 28 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more funds holding in top 10

Funds holding in top 10: 1 → 3 (+2)

107% more repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 28

81% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 16

56% more call options, than puts

Call options by funds: $22.7M | Put options by funds: $14.6M

46% more capital invested

Capital invested by funds: $812M → $1.19B (+$374M)

9% more funds holding

Funds holding: 127 → 139 (+12)

Holders
139
Holders Change
+12
Holders Change %
+9.45%
% of All Funds
3.71%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.08%
New
29
Increased
58
Reduced
28
Closed
16
Calls
$22.7M
Puts
$14.6M
Net Calls
+$8.1M
Net Calls Change
+$13.5M

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$28.1M
2
BB
BB Biotech
Switzerland
+$25.2M
3
O
OrbiMed
New York
+$21.3M
4
EC
EcoR1 Capital
California
+$8.8M
5
Norges Bank
Norges Bank
Norway
+$7.08M

Top Sellers

Rank Fund Capital Flow
1
VAM
Visium Asset Management
New York
-$31.4M
2
Millennium Management
Millennium Management
New York
-$22.1M
3
EAM
EverPoint Asset Management
Connecticut
-$12.6M
4
SAM
Senzar Asset Management
New York
-$8.56M
5
Renaissance Technologies
Renaissance Technologies
New York
-$6.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
DekaBank Deutsche Girozentrale
51
DekaBank Deutsche Girozentrale
Germany
$2.85M +$2.73M +76,000 New
California State Teachers Retirement System (CalSTRS)
52
California State Teachers Retirement System (CalSTRS)
California
$2.79M +$555K +15,453 +27%
SM
53
Sabby Management
Florida
$2.79M -$218K -6,057 -8%
D.E. Shaw & Co
54
D.E. Shaw & Co
New York
$2.66M +$2.46M +68,412 New
Lord, Abbett & Co
55
Lord, Abbett & Co
New Jersey
$2.52M -$3.11M -86,448 -57%
State of New Jersey Common Pension Fund D
56
State of New Jersey Common Pension Fund D
New Jersey
$2.43M – – –
GH
57
GAM Holding
Switzerland
$2.38M +$2.21M +61,400 New
SCM
58
Suffolk Capital Management
New York
$2.36M -$9.99K -278 -0.5%
California Public Employees Retirement System
59
California Public Employees Retirement System
California
$2.23M -$64.7K -1,800 -3%
AllianceBernstein
60
AllianceBernstein
Tennessee
$2.15M +$870K +24,200 +78%
Swiss National Bank
61
Swiss National Bank
Switzerland
$2.12M – – –
AWCI
62
Alpine Woods Capital Investors
New York
$2.06M – – –
CCM
63
Cupps Capital Management
Illinois
$2.02M +$2.23K +62 +0.1%
American Century Companies
64
American Century Companies
Missouri
$1.9M +$1.76M +48,896 New
WMSA
65
Weiss Multi-Strategy Advisers
New York
$1.84M -$3.92M -109,115 -70%
Macquarie Group
66
Macquarie Group
Australia
$1.83M +$1.7M +47,200 New
NIP
67
Nicholas Investment Partners
California
$1.8M +$1.67M +46,400 New
WC
68
Wexford Capital
Florida
$1.48M – – –
PNC Financial Services Group
69
PNC Financial Services Group
Pennsylvania
$1.41M -$411K -11,443 -24%
FSA
70
Franklin Street Advisors
North Carolina
$1.3M -$52.1K -1,450 -4%
RhumbLine Advisers
71
RhumbLine Advisers
Massachusetts
$1.29M +$255K +7,098 +27%
EA
72
Emerald Acquisition
Washington
$1.28M +$1.19M +33,123 New
N
73
Nuveen
North Carolina
$1.27M +$500K +13,928 +74%
New York State Common Retirement Fund
74
New York State Common Retirement Fund
New York
$1.14M -$528K -14,708 -33%
Ohio Public Employees Retirement System (OPERS)
75
Ohio Public Employees Retirement System (OPERS)
Ohio
$1.13M – – –
1 2
3
4 5

ITCI Hedge Fund Activity: Q2 2016 in Review

139 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Intra-Cellular Therapies Inc. (ITCI) for Q2 2016, worth a combined $1.19B — up 46% from $812M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new ITCI positions and 16 closed out — a net gain of 13 holders — while 58 added to existing stakes and 28 trimmed.

The largest buyer was Vanguard Group, adding an estimated $28.1M. The largest seller was Visium Asset Management, cutting an estimated $31.4M.

  • 139 institutional investors held Intra-Cellular Therapies Inc. (ITCI) as of Q2 2016, up from 127 in Q1 2016.
  • Funds reported $1.19B of Intra-Cellular Therapies Inc. stock for Q2 2016, up 46% quarter-over-quarter.
  • 29 funds opened new Intra-Cellular Therapies Inc. positions in Q2 2016 and 16 closed out, a net change of +13 holders.
  • The largest Intra-Cellular Therapies Inc. buyer in Q2 2016 was Vanguard Group, an estimated $28.1M added.
  • The largest Intra-Cellular Therapies Inc. seller in Q2 2016 was Visium Asset Management, an estimated $31.4M sold.

Based on aggregated 13F filings for Q2 2016.